Ikenna Okpareke, MD
Interventional Pain Medicine · Joliet, ILNPI 1912218009
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,888 of the $13,025 with a category attached, or 83.6%. It is spread thinly across 33 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.
Across 410 payments — averaging $31.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$3K
- Biotronik NRO, Inc.$1K
- Relievant Medsystems, Inc.$999
- Abbott$920
- Curonix LLC$802
- plus $4K from 27 others
What the payments were for
- Travel & lodging$2,01015%
- Food & beverage$10,88884%
- Education$1281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 58 | $2,676 |
| Boston Scientific | 50 | $2,526 |
| Biotronik NRO, Inc. | 66 | $1,280 |
| Relievant Medsystems, Inc. | 8 | $999 |
| Abbott | 37 | $920 |
| Curonix LLC | 25 | $802 |
| Nevro Corp. | 18 | $661 |
| Collegium Pharmaceutical, Inc. | 40 | $572 |
| Forte Bio-pharma LLC | 16 | $486 |
| Globus Medical | 11 | $258 |
| Scilex Pharmaceuticals Inc. | 12 | $219 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $203 |
| Saluda Medical Americas, Inc. | 10 | $202 |
| Tersera Therapeutics LLC | 9 | $185 |
| Stryker | 1 | $172 |
| Averitas Pharma Inc. | 6 | $153 |
| AbbVie | 5 | $99 |
| Azurity Pharmaceuticals, Inc. | 5 | $90 |
| Galt Pharmaceuticals, LLC | 1 | $86 |
| Nalu Medical, Inc. | 2 | $60 |
| Pacira Pharmaceuticals Incorporated | 3 | $56 |
| Painteq LLC | 2 | $40 |
| Valinor Pharma, LLC | 2 | $40 |
| Trevena, Inc. | 1 | $33 |
| Foundation Fusion Solutions, LLC | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Redhill Biopharma Inc. | 2 | $24 |
| Stimwave Technologies Incorporated | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Vertos Medical, Inc. | 1 | $23 |
| Vertex | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $18 |
| Spinal Simplicity, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,650
- Prolate$970
- SPECTRA WAVEWRITER$884
- SYNCHROMEDII$675
- Prospera$412
- VANTA ADAPTIVESTIM$280
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$264
- Nalocet$242
- GENERAL PAIN MANAGEMENT$222
- mild Device Kit$172
- Proclaim Family of SCS IPGs$155
- WaveWriter Alpha Prime 16$148
- Proclaim IPG$139
- StimQ Receiver Stimulator Kit Channel A US w Receiver$134
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$134
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$134
- Freedom 4A Receiver Kit Channel A US w Receiver$134
- Freedom 8A Receiver Kit Channel A US w Receiver$134
- RESTORE$127
- INTELLIS ADAPTIVESTIM$118
How this compares
$13,025 in reported general payments places this provider in the 80th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 111 | $88,738 |
| Xtampza ErOxycodone Myristate | 88 | $43,868 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,219 | $32,060 |
| ZtlidoLidocaine | 45 | $22,313 |
| MovantikNaloxegol Oxalate | 44 | $19,472 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 902 | $19,423 |
| Nucynta ErTapentadol Hcl | 21 | $17,987 |
| Buprenorphine | 43 | $12,627 |
| LyricaPregabalin | 14 | $10,734 |
| LinzessLinaclotide | 18 | $9,826 |
| Pregabalin | 434 | $7,973 |
| Oxycodone Hcl | 421 | $7,446 |
| Hysingla ErHydrocodone Bitartrate | 11 | $5,715 |
| Gabapentin | 271 | $3,213 |
| Morphine Sulfate ErMorphine Sulfate | 143 | $3,193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $572 | $150,594220 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $219 | $22,31345 claims |
| Redhill Biopharma Inc.Movantik | $24 | $19,47244 claims |
| AbbVieLinzess | $99 | $9,82618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 93 interventional pain medicine providers in Illinois.
Other interventional pain medicine in Joliet
- Joel SeeJoliet$3K
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.